Health Benefits of Resistance Training
In the pursuit of a healthier and more fulfilling life, exercise plays a pivotal role. Among the diverse forms of exercise, resistance training stands...
March 23, 2020: Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Dapagliflozin Tablets, 5 mg and 10 mg, the generic version of Farxiga®1 Tablets, 5 mg and 10 mg, of AstraZeneca AB. According to IQVIATM sales data for the 12 month period ending January 2020, the Farxiga® Tablets, 5 mg and 10 mg market2 achieved annual sales of approximately $1.8 billion*. Glenmark’s current portfolio consists of 165 products authorized for distribution in the U.S. marketplace and 45 ANDA’s pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.
In the pursuit of a healthier and more fulfilling life, exercise plays a pivotal role. Among the diverse forms of exercise, resistance training stands...
Menstrual discomfort is one of the most common experiences that the majority of people with menstrual cycles are likely to face. It can range from mil...
Conjunctivitis is commonly known as pink eye, and it is an eye condition that includes inflammation of the conjunctiva, the thin clear tissue that lin...